Source: ALL
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cytochrome P450 family 17 subfamily A member 1 | 0.462 | 0.769 | 2.6E-04 |
|
disease | 0.100 | None | 0.929 | 14 | 1 | 2001 | 2018 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 0.100 | None | 1.000 | 14 | 2 | 2000 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.100 | None | 1.000 | 14 | 1 | 2002 | 2020 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.100 | None | 0.923 | 13 | 0 | 2004 | 2018 | ||||||||
|
mucin 16, cell surface associated | 0.479 | 0.808 | 8.3E-112 |
|
disease | 0.100 | None | 1.000 | 13 | 0 | 2016 | 2019 | ||||||||
|
G protein-coupled estrogen receptor 1 | 0.505 | 0.731 | 0.57 |
|
disease | 0.100 | None | 0.833 | 12 | 0 | 2006 | 2019 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
disease | 0.100 | None | 0.917 | 12 | 1 | 1997 | 2020 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
disease | 0.100 | None | 1.000 | 12 | 0 | 1994 | 2019 | ||||||||
|
cytochrome P450 family 1 subfamily A member 1 | 0.436 | 0.846 | 1.1E-17 |
|
disease | 0.100 | None | 0.636 | 11 | 3 | 1997 | 2013 | ||||||||
|
cytochrome P450 family 1 subfamily B member 1 | 0.457 | 0.769 | 2.2E-05 |
|
disease | 0.100 | None | 0.818 | 11 | 5 | 2003 | 2013 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
disease | 0.100 | None | 0.818 | 11 | 5 | 2001 | 2019 | ||||||||
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2015 | 2020 | ||||||||
|
L1 cell adhesion molecule | 0.475 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0.909 | 11 | 0 | 2016 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.100 | None | 0.909 | 11 | 0 | 2001 | 2019 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2010 | 2019 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2003 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.280 | None | 0.889 | 9 | 0 | 2000 | 2019 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 2007 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.090 | None | 0.889 | 9 | 2 | 2005 | 2019 | ||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 2002 | 2020 | |||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.090 | None | 1.000 | 9 | 1 | 1992 | 2018 | ||||||||
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
disease | 0.090 | None | 0.889 | 9 | 0 | 2012 | 2019 | ||||||||
|
prominin 1 | 0.410 | 0.846 | 1.9E-22 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 2010 | 2019 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
disease | 0.090 | None | 1.000 | 9 | 2 | 2005 | 2020 | ||||||||
|
MT-CO2 pseudogene 12 | 0.368 | 0.962 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2002 | 2020 |